Items where authors include "Bansal, A."

Article

Cork, M. orcid.org/0000-0003-4428-2428, Danby, S., Rossi, A.B. et al. (1 more author) (2024) Dupilumab treatment in pediatric patients aged 6–11 years with severe atopic dermatitis whose disease Is not adequately controlled: a review. Drug Design, Development and Therapy, 18. pp. 277-289. ISSN 1177-8881

Cork, M.J., Thaçi, D., Eichenfield, L.F. et al. (8 more authors) (2023) Dupilumab safety and efficacy in a phase III open-label extension trial in children 6–11 years of age with severe atopic dermatitis. Dermatology and Therapy, 13. pp. 2697-2719. ISSN 2193-8210

Siegfried, E.C., Simpson, E.L. orcid.org/0000-0001-7353-5979, Cork, M.J. et al. (7 more authors) (2023) Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years. Dermatology and Therapy, 13 (9). pp. 1987-2000. ISSN 2193-8210

Paller, A.S. orcid.org/0000-0001-6187-6549, Siegfried, E.C., Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (8 more authors) (2023) Laboratory safety from a randomized 16-week phase III study of dupilumab in children aged 6 months to 5 years with moderate-to-severe atopic dermatitis. Pediatric Drugs, 25. pp. 67-77. ISSN 1174-5878

Majumdar, S., Bansal, A., Das, P.P. et al. (3 more authors) (2022) Automated evaluation of comments to aid software maintenance. Journal of Software: Evolution and Process, 34 (7). e2463. ISSN 2047-7473

Blauvelt, A., Guttman-Yassky, E., Paller, A.S. et al. (13 more authors) (2022) Long-term efficacy and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis : results through week 52 from a phase III open-label extension trial (LIBERTY AD PED-OLE). American Journal of Clinical Dermatology, 23 (3). pp. 365-383. ISSN 1175-0561

Bansal, A., Greenley, S., Mitchell, C. orcid.org/0000-0002-4790-0095 et al. (3 more authors) (2022) Optimising planned medical education strategies to develop learners' person-centredness : a realist review. Medical Education, 56 (5). pp. 489-503. ISSN 0308-0110

Paller, A.S., Beck, L.A., Blauvelt, A. et al. (9 more authors) (2022) Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—a pooled analysis of trial data. Pediatric Dermatology, 39 (2). pp. 187-196. ISSN 0736-8046

Simpson, E.L., Paller, A.S., Siegfried, E.C. et al. (10 more authors) (2021) Dupilumab demonstrates rapid and consistent improvement in extent and signs of atopic dermatitis across all anatomical regions in pediatric patients 6 years of age and older. Dermatology and Therapy, 11. pp. 1643-1656. ISSN 2193-8210

Paller, A.S., Wollenberg, A., Siegfried, E. et al. (12 more authors) (2021) Laboratory safety of dupilumab in patients aged 6–11 years with severe atopic dermatitis : results from a phase III clinical trial. Pediatric Drugs, 23 (5). pp. 515-527. ISSN 1174-5878

Cork, M.J. orcid.org/0000-0003-4428-2428, Thaçi, D., Eichenfield, L.F. et al. (12 more authors) (2021) Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled, severe atopic dermatitis: results from an open‐label phase IIa study and subsequent phase III open‐label extension study. British Journal of Dermatology, 184 (5). pp. 857-870. ISSN 0007-0963

Paller, A.S., Siegfried, E.C., Simpson, E.L. et al. (12 more authors) (2021) A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy. Journal of the European Academy of Dermatology and Venereology, 35 (2). pp. 464-475. ISSN 0926-9959

Paller, A.S., Siegfried, E.C., Thaçi, D. et al. (22 more authors) (2020) Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. Journal of the American Academy of Dermatology, 83 (5). pp. 1282-1293. ISSN 0190-9622

Bansal, A., Singh, D., Thompson, J. et al. (2 more authors) (2020) GP-facilitated teaching in hospitals: The way forward? [Response to letter]. Advances in Medical Education and Practice, 11. pp. 493-494. ISSN 1179-7258

Bansal, A., Singh, D., Thompson, J. et al. (2 more authors) (2020) Developing medical students’ broad clinical diagnostic reasoning through GP-facilitated teaching in hospital placements. Advances in Medical Education and Practice, 2020 (11). pp. 379-388.

Cork, M.J. orcid.org/0000-0003-4428-2428, Thaçi, D., Eichenfield, L.F. et al. (19 more authors) (2020) Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis : results from a phase IIa open‐label trial and subsequent phase III open‐label extension. British Journal of Dermatology, 182 (1). pp. 85-96. ISSN 0007-0963

Bansal, A. (2018) Greener practice: actions to improve the health of patients and the planet. Journal of Community Nursing, 32 (5). pp. 16-17. ISSN 0263-4465

Mathers, N. and Bansal, A. (2016) Patient-centered care in a multicultural world. Family Medicine and Community Health, 4 (4). pp. 1-3. ISSN 2305-6983

Beattie, R., Cummins, N., Caraher, C. et al. (7 more authors) (2016) Raman Spectroscopic Analysis of Fingernail Clippings Can Help Differentiate Between Postmenopausal Women Who Have and Have Not Suffered a Fracture. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 9. pp. 109-116. ISSN 1179-5441

Bansal, A. (2016) Turning cross-cultural medical education on its head: Learning about ourselves and developing respectful curiosity. Family Medicine and Community Health, 4 (2). pp. 41-44. ISSN 2305-6983

Bansal, A., Swann, J. and Smithson, W.H. (2014) Using professional interpreters in undergraduate medical consultation skills teaching. Advances in Medical Education and Practice, 5. pp. 439-450.

Proceedings Paper

Cork, M.J. orcid.org/0000-0003-4428-2428, Eichenfield, L.F., Blauvelt, A. et al. (9 more authors) (2019) 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis. In: Journal of Investigative Dermatology. Society for Investigative Dermatology (SID) 2019, 08-11 May 2019, Hilton Chicago, Chicago, Illinois. Elsevier , S104-S104.